Maynard Um
-
-
-
-
-
-
-
Monte Rosa Therapeutics (GLUE) PT Lowered to $30 at Guggenheim
-
-
-
-
-
-
-
Monte Rosa Therapeutics (GLUE) PT Raised to $22 at Jefferies
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Monte Rosa Therapeutics (GLUE) Following Expanded Novartis Deal
-
-
-
-
-
-
-
Monte Rosa Therapeutics (GLUE) Files $400M Mixed Shelf
-
-
-
-
-
-
-
Monte Rosa Therapeutics, Inc. (GLUE) Tops Q3 EPS by 18c
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Monte Rosa Therapeutics (GLUE)
-
-
-
-
433,566 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

